Skip to content ↓

Graduate students will present their research results at HST forum

A device that helps people who limp because of a condition called drop foot, drinking water contamination on an often-climbed Argentinian mountain and a new non-invasive treatment for brain tumors are among the research results that will be presented in student posters at the Harvard-MIT Division of Health Sciences and Technology's 2002 HST Forum on Thursday, March 14.

This year's forum, to be held the Harvard Club of Boston, 374 Commonwealth Ave., Boston, will include a talk by Eric S. Lander, director of the Whitehead Institute/MIT Center for Genome Research, titled "Beyond the Human Genome."

For more than 30 years, HST has brought together engineering, science, technology and medicine to solve problems in biology and human health. A collaboration of MIT, Harvard University, the Harvard Medical School, Boston-area teaching hospitals and research centers, HST is among the largest biomedical engineering and physician-scientist training programs in the United States.

HST students are involved in research during their medical and graduate school programs. Some conduct research while pursuing their Ph.D. or M.D. degrees, while others are engaged in nondegree-related research.

To provide students with the opportunity to present and discuss their work, the division created the HST Forum in 1987. The annual event provides an opportunity for the Harvard and MIT communities represented within HST to experience the breadth and depth of the division's biomedical and bioengineering investigations.

This year's HST Forum opens with a student poster session and reception from 2 to 4 p.m., followed by Lander's plenary address.

A version of this article appeared in MIT Tech Talk on March 13, 2002.

Related Topics

More MIT News

Globular blue and white orbs "examining" single-stranded RNA products and marking them with green checks or red x's

Why are some bacterial genes high in purines?

In certain species of bacteria, the answer lies in shielding RNA transcripts from a quality-control factor called Rho. Understanding the requirements for expressible sequences is critical for expression engineering of therapeutic agents.

Read full story

Rich Nielsen, Volha Charnysh, Kevin Dorst, and Emily Richmond Pollock seated at a table, talking

Building a scholarly community

The SHASS Faculty Fellows Program, administered by the MIT Human Insight Collaborative, is fostering new research projects and creating space for supportive and interdisciplinary discussion.

Read full story